GSK settles patent fight with Genentech; Teva unveils Seroquel versions in U.K.;

 @FiercePharma: U.S. questions India's IP regime after Nexavar move. Story | Follow @FiercePharma

> GlaxoSmithKline ($GSK) settled long-running litigation over the Genmab antibody drug it markets, in a deal with patent holders Genentech and City of Hope; terms weren't disclosed. Article

> Teva Pharmaceutical Industries ($TEVA) launched its version of AstraZeneca's ($AZN) atypical antipsychotic Seroquel in the U.K., in both instant release and extended release formulations. Report

> The state of Ohio approved a $1.5 million loan to support Abbott Laboratories' ($ABT) development of a new, $270 million plant expected to employ 240 people. News

> The U.K.'s cost-effectiveness watchdog is formulating 123 new sets of quality standards, and to help people keep track of the rules, launched its first iPhone app. Report

> German drug distributor Celesio will sell its DocMorris online pharmacy business, as well as two pharma services units, to appease their wholesaler customers. More

> Stomach surgery beat drugs at controlling blood sugar in diabetics with poorly controlled disease, a study found; its lead author called the research "a potential paradigm change." Story

> Even teenagers old enough to qualify for morning-after contraception without a prescription often are unable to obtain it because of misinformation at the pharmacy level. Report

> Teva Pharmaceutical Industries ($TEVA) won FDA approval for its allergy-fighting nasal spray Qnasl. News

> Walgreen Co. ($WAG) filled fewer prescriptions during its fiscal second quarter, thanks to the loss of its affiliation with Express Scripts ($ESRX). Report

Biotech News

 @FierceBiotech: Biogen ($BIIB) executive team rakes in millions from its 2011 successes. Article | Follow @FierceBiotech

 @JohnCFierce: Targacept ($TRGT) scuttles diabetes drug program in fresh setback. News | Follow @JohnCFierce

 @RyanMFierce: U.K.'s healthcare watchdog NICE put its quality standards on an iPhone and Android app. News | Follow @RyanMFierce

@FierceMedDev: WSJ: Ex-Olympus CEO's Next Gig: Books and Movies? More | Follow @FierceMedDev

> Lawmakers push for speedy approvals of 'breakthrough' drugs. News

> Bausch & Lomb snags experimental eye treatments in $500M ISTA buyout. More

> FDA stiff-arms Map's app for migraine therapy Levadex. Article

Manufacturing News

> Pfizer returns Xanax to UAE. Story

> Stop using DBP and DEHP, FDA says. More

> State lab in Argentina to make, distribute sildenafil. Article

> FDA slams unlicensed firm injecting 'stem cells' for cosmetic treatments. News

> Positron goes nuclear in Indiana. Item

Biotech Research News

> Stem cell research progress proliferating in 2012. Report

> NEJM: Blame chronic diarrhea on mutated gene. More

> The Vatican cancels stem cell conference. News

> Infant trauma, genetics combine to boost schizophrenia odds. Article

> Protein deficiency a tantalizing key to type 2 diabetes. Story

> Researchers coax immature brain stem cells from connective tissue. Article

And Finally... Will successful new cholesterol drugs be too pricey for today's healthcare system? Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.